Inhibrx, Inc. (INBX) Financials

INBX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 307.9 million 264.4 million
2023-09-30 372.7 million 243.1 million
2023-06-30 213.2 million 238.0 million
2023-03-31 253.7 million 238.6 million

INBX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -60.3 million 6.4 million
2023-09-30 -55.1 million 6.5 million
2023-06-30 -42.6 million 6.3 million
2023-03-31 -40.0 million 5.6 million

INBX Net Income

No data available :(

INBX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 277.9 million - 3.2 million
2023-09-30 337.3 million - 3.7 million
2023-06-30 192.5 million 204.5 million 4.1 million
2023-03-31 234.3 million 203.3 million 4.6 million

INBX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 54.0 million
2023-09-30 47.2 million
2023-06-30 43.6 million
2023-03-31 43.6 million

INBX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 3.4 million 81.8 million 7.8 million 46000
2023-09-30 811000 38.1 million 7.9 million -
2023-06-30 317000 34.1 million 7.3 million -
2023-03-31 23000 37.4 million 6.4 million -

INBX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.6 million 298000
2023-09-30 119000 304000
2023-06-30 30000 731000
2023-03-31 17000 722000

INBX

Price: $34.01

52 week price:
14.31
39.79

Earnings Per Share: -5.12 USD

P/E Ratio: -8.80

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 275430

Market Capitalization: 1.7 billion

Links: